Volume 90 Issue 22 | p. 27 | Concentrates
Issue Date: May 28, 2012

Takeda To Shut Down San Francisco Site

Department: Business
Keywords: pharmaceuticals, restructuring, biologics

Takeda is shuttering its San Francisco R&D site and shifting some biologics research to its San Diego facility. The move comes several months after the Japanese firm said it will cut 9% of its workforce, or 2,800 employees, and consolidate R&D around the world. Takeda says the plan to merge California activities will “enhance communication and collaboration.” The San Diego site will focus on using structure-based drug discovery and antibody technology to develop drugs for metabolic diseases, cancer, and immunology.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment